论文部分内容阅读
为探讨电化学疗法对中晚期肺癌的治疗效果。特选择为不适于外科手术的年老体弱或伴有心肺肝肾功能不全以及经放、化疗等治疗无效的病例进行临床观察。应用特制的电化学治癌仪，分别将阳极和阴极铂金针准确地插入肿瘤内，每根针之间距离为2cm并用导线将针连接在治疗仪上通电治疗。近期效果415例中获CR105例（25．3％）；PR193例（46．5％）；CN63例（15．1％）；PD54例（13．0％）。CR、PR评为有效共298例（71．8％）。1年生存率85．7％（356／415），2年生存率76．4％，3年生存率58．8％，4年生存率39．9％，5年生存率29．5％。本疗法能杀灭肺内巨块肿瘤，对不能接受手术或放化疗无效肺癌患者提供了新的治疗方法。
To explore the effect of electrochemical therapy on the treatment of advanced lung cancer. Specially selected for the frail elderly or incompatible with surgery, liver and kidney insufficiency, as well as chemotherapy, chemotherapy and other cases of ineffective treatment for clinical observation. Using a special electrochemical instrument for cancer treatment, the anode and cathode platinum needles were accurately inserted into the tumor, and the distance between each needle was 2 cm and the needle was connected to the therapeutic apparatus with a wire to be electrified. Among the 415 cases, 135 cases had CR 105 cases (25.3%); PR 193 cases (46.5%); CN63 cases (15.1%); PD 54 cases (13.0%). CR and PR were rated as effective in 298 cases (71.8%). The 1-year survival rate was 85.7% (356/415), the 2-year survival rate was 76.4%, the 3-year survival rate was 58.8%, the 4-year survival rate was 39.9%, and the 5-year survival rate was 29.5%. This therapy can kill massive tumors in the lung and provide new treatments for lung cancer patients who cannot undergo surgery or chemotherapy.